All companies › EZRA

EZRA · Reliance Global Group, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells5
Research cases0
Last filing2026-08-03

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-08-03 — Fruchtzweig Ben · sold 7,448 @ $4.08 2026-08-03 — Beyman Yaakov · sold 1,000 @ $3.31 2026-08-03 — Beyman Yaakov · sold 8,120 @ $3.90 2026-08-03 — Blumenfrucht Alex · sold 8,830 @ $3.97 2026-08-03 — Markovits Joel · sold 9,329 @ $2.55
2026-08-032026-08-03

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Beyman Yaakov Exec VP, Insurance Division
Fruchtzweig Ben Director
Blumenfrucht Alex Director
Markovits Joel Chief Financial Officer
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $EZRA is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-08-03', 'insider_name': 'Fruchtzweig Ben', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 7448.0, 'price': 4.08, 'value': 30387.84, 'is_buy': False}, {'transaction_date': '2026-08-03', 'insider_name': 'Beyman Yaakov', 'insider_title': 'Exec VP, Insurance Division', 'transaction_type': 'Open-market sell', 'shares': 1000.0, 'price': 3.31, 'value': 3310.0, 'is_buy': False}, {'transaction_date': '2026-08-03', 'insider_name': 'Beyman Yaakov', 'insider_title': 'Exec VP, Insurance Division', 'transaction_type': 'Open-market sell', 'shares': 8120.0, 'price': 3.9, 'value': 31668.0, 'is_buy': False}, {'transaction_date': '2026-08-03', 'insider_name': 'Blumenfrucht Alex', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 8830.0, 'price': 3.97, 'value': 35055.1, 'is_buy': False}, {'transaction_date': '2026-08-03', 'insider_name': 'Markovits Joel', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 9329.0, 'price': 2.55, 'value': 23788.95, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for EZRA today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.